Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Antidepressants, other common medications linked to high blood pressure

The full findings are scheduled to be presented May 16 at ACC.21. 

BASILICIA before TAVR is safe and effective, new data confirms

Researchers found that the procedure was associated with a high success rate and low mortality and stroke rates after 30 days.

Thumbnail

AI model helps clinicians predict post-TAVR infective endocarditis

To build and validate their advanced AI model, researchers explored data from nearly 78,000 TAVR hospitalizations.

COVID-19 patients with mild symptoms make a full recovery with no lingering heart issues

Researchers used medical imaging, blood work and advanced AI algorithms to examine patient health six months after a mild COVID-19 infection. 

quality imaging appropriateness clinical decision support CAS AUC

11% of TAVR sites deliver below-average care, suggesting a ‘meaningful performance gap’

The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation.

Thumbnail

COVID-19 may do long-term damage to the heart and blood vessels of young adults

Young adults who had COVID-19—even those who never had strong symptoms—may go on to have significant cardiovascular issues later in life.

Thumbnail

Fish oil supplements linked to potentially fatal heart rhythm issues

Certain patients face a "significantly greater risk of AFib" if they take fish oil supplements, the study's authors reported. 

Thumbnail

Moderate alcohol consumption may lower risk of death from CVD

The full analysis will be presented May 17 at ACC.21. 

Displaying 2793 - 2800 of 11027

Around the web

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.